ESBL and MBL mediated resistance in Pseudomonas aeruginosa: An emerging threat to clinical therapeutics

Journal of Clinical and Diagnostic Research

Volumn 5, Issue 8, 2011, Pages 1552-1554

  Peshattiwar, Prashant Durwas ^a   Peerapur, Basavaraj Virupaksappa ^b  

^a Konaseema institute of medical sciences and research foundation   (India)

^b BLDE UNIVERSITY   (India)

Author keywords

Imipenem; P.aeruginosa; Third generation cephalosporins

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; ENZYME ANALYSIS; NONHUMAN; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; SENSITIVITY ANALYSIS;

PSEUDOMONAS AERUGINOSA;

EID: 84856186715     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ibukun A, Tochukwu N, Tolu O. Occurrence of ESBL and MBL inclinical isolates of Pseudomonas aeruginosa From Lagos, Nigeria. Journal of American Science 2007; 3(4): 81-85.
2. Bradford PA. Extended spectrum ß-lactamases in the 21st century:The characterization, epidemiology and the detection of this importantresistance threat. Clin. Microbiol. Rev 2001; 14: 933-951.
3. Aggarwal R, Chaudhari U, Bala K. Detection of extended-spectrumβlactamases in Psuedomonas aeruginosa. Indian J Pathol Microbiol2008;51(2): 222-24.
4. Jaykumar S, Appalraju B. The prevalence of multi and pan drugresistant Psuedomonas aeruginosa with respect to ESBL and MBL inatertiary care hospital. Indian J Pathol Microbiol 2007; 50 (4): 922-25.
5. Walsh T R., Toleman M A., Poirel L Nordmann P. Metallo-β-lactamases:the quiet before the storm? Clinical Microbiology Reviews Apr 2005;306-25.
6. Colle JG, Miles RS, Wan B. Tests for the identification of bacteria. In: Colle JG, Fraser AG, Marimon BP, Simmons A, Editors. Mackeiand McCartney Practical Medical Microbiology, 14th ed. Edinburg:Chuchill Livingstone; 1996; 131-50.
7. Clinical and Laboratory Standards Institute. Performance standardsfor antimicrobial disk tests; Approved Standards, 9th ed. CLSIDocument M2-A9, Vol. 26 No.1 Wayne PA 2006.
8. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodgetest and the imipenem-EDTA double disk synergy test for thedifferentiation of the metallo-β-lactamase producing clinical isolatesof the Pseudomonas spp and the Acinetobacter spp. J Clin Microbiol2003; 41: 4623-29.
9. Anupurba S, Battacharjee A, Garg A, Ranjansen M. The antimicrobialsusceptibility of Psuedomonas aeruginosa isolated from woundinfections. Indian J Dermatol 2006; 51(4): 286-88.
10. Diwivedi M, Mishra A., Singh R.K., A. Azim, A.K. Baronia, K.N. Prasad. The nosocomial cross-transmission of Pseudomonas aeruginosabetween patients in a tertiary intensive care unit. Indian J PatholMicrobiol 2009;52(4): 509-13.
11. Arya M, Arya P, Biswas D, Prasad R. The antimicrobial susceptibilitypattern of the bacterial isolates from post operative wound infections. Indian J Pathol Microbiol 2005; 48(2): 266-69.
12. Obritsch MD, Fish DN, Maclaren R, Jung R. The national surveillanceof antimicrobial resistance in the Pseudomonas aeruginosa isolatesobtained from intensive care unit patients from 1993 to 2002. Antimicrob Agents Chemother 2004; 48: 4606-10.
13. Behera B., Mathur P., Das A., Kapil A., Sharma V. An evaluation offour different phenotypic techniques for detecting the metallo-β-lactamases producing Pseudomonas aeruginosa. Indian J. MedicalMicrobiology 2008; 26(3): 233-37.
14. Chaudhari U, Bhaskar H, Sharma M. The Imipenem-EDTA diskmethod for the rapid identification of metallo β lactamase producinggram negative bacteria. Indian J Med Res 2008; 127(2):406-07.
15. Varaiya A, Kulkarni N, Kulkarni M, et al. The incidence of metallo betalactamase producing Pseudomonas aeruginosa among ICU patients. Indian J Med Res 2008; 127: 398-402.
16. Navneeth BV, Sridaran D, Sahay D, Belwadi M. A preliminary studyon the metallo betalactamase producing Pseudomonas aeruginosa inhospitalised patients. Indian J Med Res 2002; 112: 264-67.
17. Manoharan A, Chatterjee S, Mathai D. The SARI study group. Detection and characterization of metallo beta lactamases producedby Pseudomonas aeruginosa. Indian J Med Microbial 2010; 28(3):241-44.
18. Picão R C., Poirel L, Gales A C., et al. The diversity of β-lactamasesproduced by ceftazidime-resistant pseudomonas aeruginosa isolatescausing bloodstream infections in Brazil. Antimicrob. AgentsChemother 2009;53(9):3908-13.